Proof of concept trial of ibudilast ophthalmic solution for accommodative asthenopia.
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2018
Price : $35 *
At a glance
- Drugs Ibudilast (Primary) ; Cyanocobalamin
- Indications Eye disorders
- Focus Proof of concept; Therapeutic Use
- 17 Dec 2018 Status changed from recruiting to completed.
- 26 Oct 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 31 Jul 2014 New trial record